These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
209 related items for PubMed ID: 31627715
1. Introduction of a standardised protocol, including systematic use of tranexamic acid, for management of severe adult trauma patients in a low-resource setting: the MSF experience from Port-au-Prince, Haiti. Jachetti A, Massénat RB, Edema N, Woolley SC, Benedetti G, Van Den Bergh R, Trelles M. BMC Emerg Med; 2019 Oct 18; 19(1):56. PubMed ID: 31627715 [Abstract] [Full Text] [Related]
2. Development and validation of a prognostic model to predict death in patients with traumatic bleeding, and evaluation of the effect of tranexamic acid on mortality according to baseline risk: a secondary analysis of a randomised controlled trial. Perel P, Prieto-Merino D, Shakur H, Roberts I. Health Technol Assess; 2013 Jun 18; 17(24):1-45, v-vi. PubMed ID: 23782457 [Abstract] [Full Text] [Related]
3. The CRASH-2 trial: a randomised controlled trial and economic evaluation of the effects of tranexamic acid on death, vascular occlusive events and transfusion requirement in bleeding trauma patients. Roberts I, Shakur H, Coats T, Hunt B, Balogun E, Barnetson L, Cook L, Kawahara T, Perel P, Prieto-Merino D, Ramos M, Cairns J, Guerriero C. Health Technol Assess; 2013 Mar 18; 17(10):1-79. PubMed ID: 23477634 [Abstract] [Full Text] [Related]
12. Tranexamic acid in the prehospital setting: Israel Defense Forces' initial experience. Lipsky AM, Abramovich A, Nadler R, Feinstein U, Shaked G, Kreiss Y, Glassberg E. Injury; 2014 Jan 20; 45(1):66-70. PubMed ID: 24074828 [Abstract] [Full Text] [Related]
13. The Effect of Tranexamic Acid on Functional Outcomes: An Exploratory Analysis of the CRASH-2 Randomized Controlled Trial. Nishijima DK, Kuppermann N, Roberts I, VanBuren JM, Tancredi DJ. Ann Emerg Med; 2019 Jul 20; 74(1):79-87. PubMed ID: 30642657 [Abstract] [Full Text] [Related]
15. The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial. CRASH-2 collaboratorsClinical Trials Unit, London School of Hygiene and Tropical Medicine, London WC1E 7HT, UK. crash@lshtm.ac.uk, Roberts I, Shakur H, Afolabi A, Brohi K, Coats T, Dewan Y, Gando S, Guyatt G, Hunt BJ, Morales C, Perel P, Prieto-Merino D, Woolley T. Lancet; 2011 Mar 26; 377(9771):1096-101, 1101.e1-2. PubMed ID: 21439633 [Abstract] [Full Text] [Related]
16. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2) A randomised, placebo-controlled trial. Williams-Johnson JA, McDonald AH, Strachan GG, Williams EW. West Indian Med J; 2010 Dec 26; 59(6):612-24. PubMed ID: 21702233 [Abstract] [Full Text] [Related]
17. Use of tranexamic acid in major trauma: a sex-disaggregated analysis of the Clinical Randomisation of an Antifibrinolytic in Significant Haemorrhage (CRASH-2 and CRASH-3) trials and UK trauma registry (Trauma and Audit Research Network) data. Nutbeam T, Roberts I, Weekes L, Shakur-Still H, Brenner A, Ageron FX. Br J Anaesth; 2022 Aug 26; 129(2):191-199. PubMed ID: 35597623 [Abstract] [Full Text] [Related]
19. Prehospital Tranexamic Acid Administration During Aeromedical Transport After Injury. Boudreau RM, Deshpande KK, Day GM, Hinckley WR, Harger N, Pritts TA, Makley AT, Goodman MD. J Surg Res; 2019 Jan 26; 233():132-138. PubMed ID: 30502239 [Abstract] [Full Text] [Related]
20. Time since injury is the major factor in preventing tranexamic acid use in the trauma setting: An observational cohort study from a major trauma centre in a middle-income country. Thurston B, Chowdhury S, Edu S, Nicol AJ, Navsaria PH. S Afr J Surg; 2015 Oct 08; 53(1):13-8. PubMed ID: 26449600 [Abstract] [Full Text] [Related] Page: [Next] [New Search]